Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TRV GP IV, LLC (CIK 1688325) reported $266.9M across 2 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: MAZE ($133.5M, 50.04%), TNGX ($133.4M, 49.96%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MAZE | MAZE THERAPEUTICS, INC. | $133.5M | 50.04% | 4.5M | Hold |
| 2 | TNGX | TANGO THERAPEUTICS, INC. | $133.4M | 49.96% | 6.4M | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31